Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C24H20Cl2F4N6O is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1407496-16-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1407496-16-5 Structure
  • Basic information

    1. Product Name: C24H20Cl2F4N6O
    2. Synonyms: C24H20Cl2F4N6O
    3. CAS NO:1407496-16-5
    4. Molecular Formula:
    5. Molecular Weight: 555.362
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1407496-16-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C24H20Cl2F4N6O(CAS DataBase Reference)
    10. NIST Chemistry Reference: C24H20Cl2F4N6O(1407496-16-5)
    11. EPA Substance Registry System: C24H20Cl2F4N6O(1407496-16-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1407496-16-5(Hazardous Substances Data)

1407496-16-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1407496-16-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,7,4,9 and 6 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1407496-16:
(9*1)+(8*4)+(7*0)+(6*7)+(5*4)+(4*9)+(3*6)+(2*1)+(1*6)=165
165 % 10 = 5
So 1407496-16-5 is a valid CAS Registry Number.

1407496-16-5Downstream Products

1407496-16-5Relevant articles and documents

Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors

Wu, Kui,Ai, Jing,Liu, Qiufeng,Chen, Tiantian,Zhao, Ailing,Peng, Xia,Wang, Yuanxiang,Ji, Yinchun,Yao, Qizheng,Xu, Yechun,Geng, Meiyu,Zhang, Ao

, p. 6368 - 6372 (2012/11/07)

Two series of new analogues were designed by replacing the quinoline scaffold of our earlier lead 2 (zgwatinib) with quinoxaline and pyrido[2,3-d]pyrimidine frameworks. Moderate c-Met inhibitory activity was observed in the quinoxaline series. Among the p

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1407496-16-5